---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-027028"
form_type: "8-K"
ticker: "AQST"
cik: "0001398733"
company_name: "Aquestive Therapeutics, Inc."
filed_at: "2024-06-06T23:59:59+00:00"
generated_at: "2026-06-01T05:51:00.514736+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Aquestive Therapeutics promotes Cassie Jung to COO effective June 3, 2024

## Summary
- Cassie Jung, 45, promoted to Chief Operating Officer, effective June 3, 2024.
- Jung joined Aquestive in 2004 and served as VP Operations since 2019.
- Annual base salary increased to $349,800; target incentive at least 40% of base.
- No family relationships with directors/officers or reportable transactions.
- Employment agreement will be filed with next 10-Q.

## SEC filing metadata
- accession: 0001628280-24-027028
- form_type: 8-K
- ticker: AQST
- cik: 0001398733
- company_name: Aquestive Therapeutics, Inc.
- filed_at: 2024-06-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1398733/000162828024027028/0001628280-24-027028-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1398733/000162828024027028/aqst-20240603.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-027028
- JSON: https://secwatch.observer/filing/0001628280-24-027028.json
- Plain text: https://secwatch.observer/filing/0001628280-24-027028.txt

## Key facts
- Executive change
  Cassie Jung changed role as Chief Operating Officer at Aquestive Therapeutics, Inc..
  - Action: promoted
  - Role: Chief Operating Officer
  source text: Aquestive Therapeutics, Inc. (the “Company”) has promoted Cassie Jung, 45, to Chief Operating Officer, effective June 3, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1398733/000162828024027028/0001628280-24-027028-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.